Loading...
Loading...
ACST| Name | Value |
|---|---|
| Revenues | 4,833.0K |
| Cost of Revenue | 4,832.0K |
| Gross Profit | 1.0K |
| Operating Expense | 3,184.0K |
| Operating I/L | 9,794.0K |
| Other Income/Expense | 0.0K |
| Interest Income | 407.0K |
| Pretax | -382.0K |
| Income Tax Expense | 1,576.0K |
| Net Income/Loss | -1,958.0K |
Acasti Pharma Inc. is a biopharmaceutical company specializing in the development and commercialization of pharmaceutical products for cardiovascular diseases. The company's primary focus is on the clinical development of CaPre, a potential treatment for cardiovascular conditions. Acasti Pharma Inc. generates revenue through strategic partnerships and the eventual commercialization of its pharmaceutical products.
